Alkermes plc. (ALKS) Q3 FY2026 earnings: revenue $480 million, up 21.8% on the year
Alkermes plc. (ALKS) reported revenue of $480 million for Q3 FY2026, the quarter ended 30 September 2026, up 21.8% on the same quarter a year earlier. Net income was $16 million, down 80.3% on the year, and diluted earnings per share $0.09. The figures are the company's own, from the 10-Q it filed with the SEC on 3 November 2026.
Revenue
$480 million
+21.8% on the year · -3.2% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
7.5%
22.6% a year earlier
Q4 FY2024Q3 FY2026
Net income
$16 million
-80.3% on the year · +3,150.9% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.09
-81.6% on the year
Q4 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 16 kept.
Revenue and net income reported: Total revenues were $480.1 million against $394.2 million a year earlier. GAAP net income was $16.3 million against $82.8 million; diluted EPS was $0.09 against $0.49. Adjusted EBITDA was $120.1 million against $121.5 million.
LUMRYZ revenue and patient count: LUMRYZ revenues were $89.9 million, with about 4,100 patients on therapy at quarter end. The prior-year quarter had no LUMRYZ revenue.
Avadel costs within expense lines: GAAP cost of goods was $94.2 million, R&D $121.1 million and SG&A $208.5 million. Costs related to the acquisition of Avadel were $29.8 million in the quarter and $118.1 million for nine months.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
93.5
145
102
-35.6%
-8.1%
Capital expenditure
3.4
8.1
17.3
-58.2%
-80.4%
Free cash flow
90.1
137
84.4
-34.3%
+6.8%
Free cash flow margin
18.8%
27.6%
21.4%
Cash from investing
20.0
-2.4
-6.7
Cash from financing
6.3
17.2
0.3
-63.3%
+1,905.7%
Depreciation and amortisation
27.2
30.3
8.1
-10.3%
+236.1%
Share-based compensation
26.7
31.1
24.7
-14.1%
+8.4%
Buybacks
0.0
0.0
0.0
Diluted shares, weighted
176m
173m
169m
+1.7%
+4.7%
Shares outstanding at period end
168m
168m
165m
+0.3%
+1.8%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
1,865
1,809
1,733
+3.1%
+7.6%
Debt
1,512
1,525
0.0
-0.9%
Operating lease liabilities
65.8
62.0
65.0
+6.1%
+1.2%
Other liabilities
993
998
531
-0.4%
+87.0%
Total liabilities and equity
4,436
4,393
2,330
+1.0%
+90.4%
Fixed assets
215
218
247
-1.5%
-12.9%
Goodwill
593
594
n/a
-0.3%
Intangible assets
1,742
1,761
n/a
-1.1%
Investments
156
180
523
-13.2%
-70.1%
Cash and equivalents
631
512
616
+23.4%
+2.4%
Receivables
459
456
354
+0.6%
+29.5%
Inventory
261
299
191
-12.7%
+36.7%
Other assets
378
372
398
+1.7%
-4.9%
Total assets
4,436
4,393
2,330
+1.0%
+90.4%
Questions
What was Alkermes plc.'s revenue in Q3 FY2026?
Alkermes plc. (ALKS) reported revenue of $480 million for Q3 FY2026, the quarter ended 30 September 2026, up 21.8% on the same quarter a year earlier.
How much did Alkermes plc. earn in Q3 FY2026?
Net income for Q3 FY2026 was $16 million, down 80.3% on the year, and diluted earnings per share $0.09.
When did Alkermes plc. report Q3 FY2026 results?
Alkermes plc. filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 3 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 3 November 2026: the filing.